Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 16, 2004; DOI: 10.1124/jpet.103.060574
0022-3565/04/3092-697-704$20.00
JPET 309:697-704, 2004
INFLAMMATION AND IMMUNOPHARMACOLOGY
In Vivo Activity of a Phospholipase C Inhibitor, 1-(6-((17
-3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), in Acute and Chronic Inflammatory Reactions
Cuifen Hou,
Thomas Kirchner,
Monica Singer,
Michele Matheis,
Dennis Argentieri, and
Druie Cavender
Department of Drug Discovery, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Raritan, New Jersey
To investigate the role of phospholipase C (PLC) in inflammatory processes, we tested 1-(6-((17
-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), a widely used PLC inhibitor, in several in vitro and in vivo assays. We first examined the effects of U73122 on human phospholipase C-
(PLC-
) isozymes and found that U73122 significantly inhibited recombinant human PLC-
2, with an IC50 of
6 µM. U73122 had little effect on PLC-
1, PLC-
3, or PLC-
4. Consistent with its ability to inhibit PLC-
2 enzymatic activity, U73122 reduced interleukin-8 and leukotriene B4-induced Ca2+ flux and chemotaxis in human neutrophils in a concentration-dependent manner. In vivo, U73122 blocked carrageenan-induced hind paw edema in rats, carrageenan-induced macrophage and lymphocyte accumulation into subcutaneous chambers in dogs, lipopolysaccharide-induced macrophage, lymphocyte infiltration and prostaglandin E2 production in a mouse peritonitis model, and 12-O-tetradecanoylphorbol-13-acetate-induced ear edema in mice. These results implicate PLC-dependent signaling pathways in the development of acute and chronic inflammatory responses in vivo.
Received September 26, 2003;
accepted December 22, 2003.
Address correspondence to: Dr. Cuifen Hou, Johnson and Johnson Pharmaceutical Research and Development, L.L.C., Drug Discovery, 1000 Route 202, Rm B-110, P.O. Box 300, Raritan, NJ 08869. E-mail: chou{at}prdus.jnj.com
This article has been cited by other articles:

|
 |

|
 |
 
V. Kolsch, P. G. Charest, and R. A. Firtel
The regulation of cell motility and chemotaxis by phospholipid signaling
J. Cell Sci.,
March 1, 2008;
121(5):
551 - 559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Poeckel, L. Tausch, S. George, J. Jauch, and O. Werz
3-O-Acetyl-11-keto-boswellic Acid Decreases Basal Intracellular Ca2+ Levels and Inhibits Agonist-Induced Ca2+ Mobilization and Mitogen-Activated Protein Kinase Activation in Human Monocytic Cells
J. Pharmacol. Exp. Ther.,
January 1, 2006;
316(1):
224 - 232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Feisst, L. Franke, G. Appendino, and O. Werz
Identification of Molecular Targets of the Oligomeric Nonprenylated Acylphloroglucinols from Myrtus communis and Their Implication as Anti-Inflammatory Compounds
J. Pharmacol. Exp. Ther.,
October 1, 2005;
315(1):
389 - 396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Basset, F.-X. Boittin, O. M. Dorchies, J.-Y. Chatton, C. van Breemen, and U. T. Ruegg
Involvement of Inositol 1,4,5-Trisphosphate in Nicotinic Calcium Responses in Dystrophic Myotubes Assessed by Near-plasma Membrane Calcium Measurement
J. Biol. Chem.,
November 5, 2004;
279(45):
47092 - 47100.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.